“Claire Farr founded Klaire Labs at her kitchen table with a dream to create supplements pure enough that highly sensitive individuals like herself could tolerate reliably,” said Ilene Buchholz, RN, a former colleague of Claire Farr and current technical education lead for Klaire Labs. “She was truly a humanitarian as well as a consummate entrepreneur dedicated to providing the purest, most potent, pharmacy grade nutraceuticals.”
Since the acquisition by Soho Flordis International (SFI) in 2013, the three originating brands in 
Reno have benefited by both aligned philosophy and significant investment. The newly harmonized Klaire Labs has a new 75,000 square foot state-of-the-art manufacturing facility, which will allow the company to assure optimized quality processes and advanced formulation expertise in its significantly expanded manufacturing capability.
“We want our practitioners to know that the new facility and unification of brands are only the outward manifestations of our growth,” said Jeremy Appleton, ND, Vice President of Scientific and Regulatory Affairs. “Internally, these changes are supported by investments in robust and streamlined quality systems, experienced staff, and regulatory and production expertise second to none. There have been some bumps along the way, but we are confident these changes will have the ultimate effect of elevating us far above most companies operating in this channel. Such improvements tangibly support practitioners in their patient care, including a pipeline of new and innovative products.”
As a component of the unification, practitioners can expect to see a new, modernized branding with a clear and respectful nod to the legacy Klaire Labs logo and labeling. The refreshed look will begin to surface in late 2017.
For more information and FAQs on the unification of ProThera and Complementary Prescriptions under the Klaire Labs umbrella, to learn the Claire Farr story, and to subscribe to updates on the consolidation, please visit MeetKlaire.com.
Klaire Labs has been formulating and manufacturing premium, hypoallergenic supplements sold through healthcare practitioners for nearly half a century. Our mission is to develop and manufacture the purest, most potent nutraceuticals possible, thereby empowering clinicians with consistently reliable performance. Klaire Labs is located in Reno, NV. It is owned by Soho Flordis International, a privately held nutraceutical company based in Sydney, Australia.
Klaire Labs Branding Merger with ProThera and Complementary Prescriptions
In coming months, you may notice a change in branding of some professional-line supplements as three popular practitioner brands merge into one label. In early July 2017, Klaire Labs (parent Soho Flordis International, SFI USA) announced that ProThera and and Complementary Prescriptions will unify under the Klaire Labs brand.
Klaire Labs has a long history of producing dietary supplements with the highest of purity and potency principles. As such, every product will now be evaluated through the highly discriminating Klaire Labs quality lens.
“Claire Farr founded Klaire Labs at her kitchen table with a dream to create supplements pure enough that highly sensitive individuals like herself could tolerate reliably,” said Ilene Buchholz, RN, a former colleague of Claire Farr and current technical education lead for Klaire Labs. “She was truly a humanitarian as well as a consummate entrepreneur dedicated to providing the purest, most potent, pharmacy grade nutraceuticals.”
Since the acquisition by Soho Flordis International (SFI) in 2013, the three originating brands in
Reno have benefited by both aligned philosophy and significant investment. The newly harmonized Klaire Labs has a new 75,000 square foot state-of-the-art manufacturing facility, which will allow the company to assure optimized quality processes and advanced formulation expertise in its significantly expanded manufacturing capability.
“We want our practitioners to know that the new facility and unification of brands are only the outward manifestations of our growth,” said Jeremy Appleton, ND, Vice President of Scientific and Regulatory Affairs. “Internally, these changes are supported by investments in robust and streamlined quality systems, experienced staff, and regulatory and production expertise second to none. There have been some bumps along the way, but we are confident these changes will have the ultimate effect of elevating us far above most companies operating in this channel. Such improvements tangibly support practitioners in their patient care, including a pipeline of new and innovative products.”
As a component of the unification, practitioners can expect to see a new, modernized branding with a clear and respectful nod to the legacy Klaire Labs logo and labeling. The refreshed look will begin to surface in late 2017.
For more information and FAQs on the unification of ProThera and Complementary Prescriptions under the Klaire Labs umbrella, to learn the Claire Farr story, and to subscribe to updates on the consolidation, please visit MeetKlaire.com.
Klaire Labs has been formulating and manufacturing premium, hypoallergenic supplements sold through healthcare practitioners for nearly half a century. Our mission is to develop and manufacture the purest, most potent nutraceuticals possible, thereby empowering clinicians with consistently reliable performance. Klaire Labs is located in Reno, NV. It is owned by Soho Flordis International, a privately held nutraceutical company based in Sydney, Australia.
Related Articles
Understanding and Treating the Pain/Sleep Connection
Read MorePaper Receipts and Xenoestrogens
Read More3 Published Studies: Modified Citrus Pectin Protects Neurological Function, Improves Brain Health & Reduces Nerve Damage
Read More